ProPhase Labs (PRPH) Set to Announce Earnings on Thursday

ProPhase Labs (NASDAQ:PRPH - Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Thursday, May 9th. Analysts expect ProPhase Labs to post earnings of ($0.28) per share for the quarter. Investors interested in registering for the company's conference call can do so using this link.

ProPhase Labs (NASDAQ:PRPH - Get Free Report) last released its quarterly earnings results on Thursday, March 28th. The company reported ($0.51) earnings per share (EPS) for the quarter. The company had revenue of $3.50 million during the quarter, compared to the consensus estimate of $10.71 million. ProPhase Labs had a negative return on equity of 29.83% and a negative net margin of 37.81%. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

ProPhase Labs Stock Up 2.1 %

Shares of PRPH traded up $0.11 on Friday, reaching $5.42. The stock had a trading volume of 38,391 shares, compared to its average volume of 45,319. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.10 and a current ratio of 2.28. ProPhase Labs has a 12-month low of $4.05 and a 12-month high of $9.94. The firm has a market capitalization of $97.83 million, a price-to-earnings ratio of -5.53 and a beta of -0.17. The company has a 50-day simple moving average of $5.54 and a 200-day simple moving average of $5.03.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a "buy" rating and set a $11.00 target price on shares of ProPhase Labs in a report on Wednesday, February 21st.

ProPhase Labs Company Profile

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.